Agency Information Collection Activities: Submission for OMB Review; Comment Request, 19744-19745 [2017-08588]
Download as PDF
<![CDATA[
19744
Federal Register / Vol. 82, No. 81 / Friday, April 28, 2017 / Notices
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: April 25, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 25, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–08626 Filed 4–27–17; 8:45 am]
Center for Scientific Review; Notice of
Closed Meeting
[FR Doc. 2017–08627 Filed 4–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIGMS Initial Review
GroupTraining and Workforce Development
Subcommittee—C To review R25 Research
Training Grant applications.
Date: June 22–23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree By Hilton Bethesda,
8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Lee Warren Slice, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 1
Democracy Plaza, 6701 Democracy Blvd.
Room 1068, Bethesda, MD 20892, 301–435–
0807, slicelw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
VerDate Sep<11>2014
17:38 Apr 27, 2017
Jkt 241001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; P30 and R24 Review.
Date: May 23, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Capital View, 2850
South Potomac Avenue, Arlington, VA
22202.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–9223, JimokKim@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 25, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–08631 Filed 4–27–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR17–033:
Integrative Research to Understand the
Impact of Sex Differences on the Molecular
Determinants of AD Risk and Responsiveness
to Treatment.
Date: May 24, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexei Kondratyev, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, 301–435–
1785, kondratyevad@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 25, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–08624 Filed 4–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
Frm 00093
Fmt 4703
Sfmt 4703
E:\FR\FM\28APN1.SGM
28APN1
19745
Federal Register / Vol. 82, No. 81 / Friday, April 28, 2017 / Notices
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Mandatory Guidelines for
Federal Workplace Drug Testing
Programs (OMB No. 0930–0158)—
Revision
SAMHSA will request OMB approval
for the Federal Drug Testing Custody
and Control Form (CCF) for federal
agency and federally regulated drug
testing programs which must comply
with the HHS Mandatory Guidelines for
Federal Workplace Drug Testing
Programs using Urine (82 FR 7920)
dated January 23, 2017, and OMB
approval for information provided by
test facilities (laboratories and
Instrumented Initial Test Facilities,
IITFs) for the National Laboratory
Certification Program (NLCP).
The CCF is used by all federal
agencies and employers regulated by the
Department of Transportation (DOT)
and the Nuclear Regulatory Commission
(NRC) to document the collection and
chain of custody of urine specimens at
the collection site, for HHS-certified test
facilities to report results, and for
Medical Review Officers (MROs) to
document and report a verified result.
SAMHSA allows the use of the CCF as
a paper or electronic form.
The current OMB-approved CCF has a
May 31, 2017 expiration date. SAMHSA
has resubmitted the CCF with minor
content revisions to the form for OMB
approval. These revisions are:
• Remove the checkbox, the letters
‘‘DOT’’, and hash line in front of Specify
DOT Agency in Step 1: Completed by
collector or employer Representative;
Line D: Specify Testing Authority.
• Addition of four new analytes
(oxycodone, oxymorphone,
hydrocodone, and hydromorphone) in
Step 5A: Primary Specimen Report—
Completed by Test Facility.
• Removal of the analyte
methylenedioxyethylamphetamine
(MDEA) in Step 5A: Primary Specimen
Report—Completed by Test Facility.
Based upon information from federal
agencies and from DOT concerning their
Custody and Control Form:
Donor ............................................................................
Collector ........................................................................
Laboratory .....................................................................
IITF ................................................................................
Medical Review Officer .................................................
NLCP Application Form:
Laboratory .....................................................................
IITF ................................................................................
Sections B and C—NLCP Inspection Checklist:
Laboratory .....................................................................
IITF ................................................................................
Recordkeeping:
Laboratory .....................................................................
IITF ................................................................................
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Total .......................................................................
Written comments and
recommendations concerning the
proposed information collection should
be sent by May 30, 2017 to the
SAMHSA Desk Officer at the Office of
Information and Regulatory Affairs,
Office of Management and Budget
(OMB). To ensure timely receipt of
comments, and to avoid potential delays
in OMB’s receipt and processing of mail
sent through the U.S. Postal Service,
commenters are encouraged to submit
their comments to OMB via email to:
OIRA_Submission@omb.eop.gov.
Although commenters are encouraged to
send their comments via email,
commenters may also fax their
comments to: 202–395–7285.
VerDate Sep<11>2014
17:38 Apr 27, 2017
Jkt 241001
Responses
per
respondent
Number of
respondents
Form/respondent
regulated industries, the number of
respondents has been reduced from a
total of 6.1 million in 2013 to 5.4
million, which reduces the total burden
hours by 188,766.
Laboratories and IITFs seeking HHS
certification under the NLCP must
complete and submit the NLCP
application form. The NLCP application
form has not been revised compared to
the previous form.
Prior to an inspection, an HHScertified laboratory or IITF is required to
submit specific information regarding
its procedures. Collecting this
information prior to an inspection
allows the inspectors to thoroughly
review and understand the testing
procedures before arriving for the onsite
inspection. The NLCP information
checklist has not been revised compared
to the previous form.
The annual total burden estimates for
the CCF, the NLCP application, the
NLCP information checklist, and the
NLCP recordkeeping requirements are
shown in the following table.
Total
number of
responses
Burden
per response
(hours)
Annual
burden
(hours)
5,400,000
5,400,000
5,400,000
0
5,400,000
1
1
1
0
1
5,400,000
5,400,000
5,400,000
0
5,400,000
0.08
0.07
0.05
0
0.05
450,000
360,000
270,000
0
270,000
1
0
1
0
1
0
3
0
3
0
30
0
1
0
30
0
1
0
30
0
30
0
1
0
30
0
250
0
7,500
0
5,400,061
........................
5,400,061
........................
1,357,533
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
DEPARTMENT OF HOMELAND
SECURITY
Summer King,
Statistician.
[Docket ID FEMA–2008–0010]
[FR Doc. 2017–08588 Filed 4–27–17; 8:45 am]
Federal Emergency Management
Agency
Board of Visitors for the National Fire
Academy
BILLING CODE 4162–20–P
PO 00000
Federal Emergency
Management Agency, DHS.
ACTION: Committee Management; Notice
of Open Federal Advisory Committee
Meeting.
AGENCY:
The Board of Visitors for the
National Fire Academy (Board) will
SUMMARY:
Frm 00094
Fmt 4703
Sfmt 4703
E:\FR\FM\28APN1.SGM
28APN1
]]>Agencies
[Federal Register Volume 82, Number 81 (Friday, April 28, 2017)]
[Notices]
[Pages 19744-19745]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under
[[Page 19745]]
OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these documents, call the SAMHSA
Reports Clearance Officer on (240) 276-1243.
Project: Mandatory Guidelines for Federal Workplace Drug Testing
Programs (OMB No. 0930-0158)--Revision
SAMHSA will request OMB approval for the Federal Drug Testing
Custody and Control Form (CCF) for federal agency and federally
regulated drug testing programs which must comply with the HHS
Mandatory Guidelines for Federal Workplace Drug Testing Programs using
Urine (82 FR 7920) dated January 23, 2017, and OMB approval for
information provided by test facilities (laboratories and Instrumented
Initial Test Facilities, IITFs) for the National Laboratory
Certification Program (NLCP).
The CCF is used by all federal agencies and employers regulated by
the Department of Transportation (DOT) and the Nuclear Regulatory
Commission (NRC) to document the collection and chain of custody of
urine specimens at the collection site, for HHS-certified test
facilities to report results, and for Medical Review Officers (MROs) to
document and report a verified result. SAMHSA allows the use of the CCF
as a paper or electronic form.
The current OMB-approved CCF has a May 31, 2017 expiration date.
SAMHSA has resubmitted the CCF with minor content revisions to the form
for OMB approval. These revisions are:
Remove the checkbox, the letters ``DOT'', and hash line in
front of Specify DOT Agency in Step 1: Completed by collector or
employer Representative; Line D: Specify Testing Authority.
Addition of four new analytes (oxycodone, oxymorphone,
hydrocodone, and hydromorphone) in Step 5A: Primary Specimen Report--
Completed by Test Facility.
Removal of the analyte methylenedioxyethylamphetamine
(MDEA) in Step 5A: Primary Specimen Report--Completed by Test Facility.
Based upon information from federal agencies and from DOT
concerning their regulated industries, the number of respondents has
been reduced from a total of 6.1 million in 2013 to 5.4 million, which
reduces the total burden hours by 188,766.
Laboratories and IITFs seeking HHS certification under the NLCP
must complete and submit the NLCP application form. The NLCP
application form has not been revised compared to the previous form.
Prior to an inspection, an HHS-certified laboratory or IITF is
required to submit specific information regarding its procedures.
Collecting this information prior to an inspection allows the
inspectors to thoroughly review and understand the testing procedures
before arriving for the onsite inspection. The NLCP information
checklist has not been revised compared to the previous form.
The annual total burden estimates for the CCF, the NLCP
application, the NLCP information checklist, and the NLCP recordkeeping
requirements are shown in the following table.
----------------------------------------------------------------------------------------------------------------
Burden per
Form/respondent Number of Responses per Total number response Annual burden
respondents respondent of responses (hours) (hours)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form:
Donor....................... 5,400,000 1 5,400,000 0.08 450,000
Collector................... 5,400,000 1 5,400,000 0.07 360,000
Laboratory.................. 5,400,000 1 5,400,000 0.05 270,000
IITF........................ 0 0 0 0 0
Medical Review Officer...... 5,400,000 1 5,400,000 0.05 270,000
NLCP Application Form:
Laboratory.................. 1 1 1 3 3
IITF........................ 0 0 0 0 0
Sections B and C--NLCP
Inspection Checklist:
Laboratory.................. 30 1 30 1 30
IITF........................ 0 0 0 0 0
Recordkeeping:
Laboratory.................. 30 1 30 250 7,500
IITF........................ 0 0 0 0 0
-------------------------------------------------------------------------------
Total................... 5,400,061 .............. 5,400,061 .............. 1,357,533
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent by May 30, 2017 to the SAMHSA
Desk Officer at the Office of Information and Regulatory Affairs,
Office of Management and Budget (OMB). To ensure timely receipt of
comments, and to avoid potential delays in OMB's receipt and processing
of mail sent through the U.S. Postal Service, commenters are encouraged
to submit their comments to OMB via email to:
OIRA_Submission@omb.eop.gov. Although commenters are encouraged to send
their comments via email, commenters may also fax their comments to:
202-395-7285. Commenters may also mail them to: Office of Management
and Budget, Office of Information and Regulatory Affairs, New Executive
Office Building, Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2017-08588 Filed 4-27-17; 8:45 am]
BILLING CODE 4162-20-P
